for Site Reads in Clinical Trials
mint Lesion™ supports radiologists in performing the
radiological Site Read for a clinical trial which assesses the
effectiveness of a cancer therapy. An optimized
workflow streamlines your work, e.g. by fast
classification and tracing of lesions throughout all
The validity of the radiological read is ensured by automated
conformity checks which are integrated for every criteria.
By accounting for all parameters required by the
response evaluation criteria of your choice, mint Lesion™
provides detailed response evaluation up to Overall
- RECIST 1.1
- RECIST 1.0
- mRECIST HCC
- Modified criteria
- irRECIST 1.1
- mRECIST Mesoth.
- Customized criteria
New targeted therapies play an increasingly significant role in the therapy of cancer patients. This, in combination with advances in medical imaging, results in new opportunities and challenges for the interdisciplinary therapy setting. Prof. Dr. Heinz-Peter Schlemmer, head of the radiology department of the German Cancer Research Center, summarizes the challenges: “Multi-disciplinary therapy approaches, combined with multimodal and multi-parametric imaging procedures and their frequent application during therapy lead to new complexities in the radiological evaluation of oncologic patients.”
A patient example for this is a 48-year-old female patient with malign melanoma of the left thigh… read more
Manually filled template for sponsor
with no link to measured lesions.
mint Lesion™ generates holistic and comprehensive reports
with automated calculation of timepoint response.
Time is not only required for the current follow-up read,
you must first and foremost find and understand the previous reads.
mint Lesion™ automatically synchronizes images and guides the user
to the slice where documented lesions are assumed to be.
No quality checks and control;
high error rate.
mint Lesion™ ensures validity of performed reads
through integrated conformity checks.
Mint Medical has designed an incredibly robust, comprehensive and easy to use software package that has revolutionized structured reporting in the assessment of treatment response in cancer patients. mint Lesion™ really is the best.- Prof. Dr. Marilyn Siegel \\ Washington University St. Louis
Using mint Lesion™, I have observed a paradigm shift that is revolutionizing my approach to oncologic patients.- Dr. Daniele Regge \\ Candiolo Cancer Institute Turin
We professionalized our oncological assessment workflows by application of mint Lesion™.- Prof. Dr. Georg Bongartz \\ University Hospital Basel
Good integration in the existing IT was important to us – appropriate interfaces to RIS and PACS were implemented quickly and professionally.- Prof. Dr. Elmar Kotter \\ University Hospital Freiburg
mint Lesion™ knows about the partially complex subtleties of assessment criteria, which makes the assessment of lesions a lot easier compared to conventional workstations.- Prof. Dr. Philippe Pereira \\ SLK Clinics Heilbronn
mint Lesion™ allows for a robust and reproducible tumor monitoring even of complex oncological therapy courses, and beyond the commonly used RECIST criteria.- PD Dr. Thorsten Persigehl \\ University Hospital Cologne
Accurate, reproducible, and standardized assessment of treatment response is of fundamental importance in oncology. A powerful yet easy to use and integrated software such as mint Lesion™ may be exactly what it takes to migrate such a capability from the world of clinical trials to everyday practice of Radiology and Oncology.- Prof. Dr. Dominik Fleischmann \\ Stanford University
The intuitive workflow is perfectly suited for the normal workflow of oncological radiological diagnosis. Even a relatively inexperienced user can get the hang of it quite quickly.- Prof. Dr. Marika Ganten \\ German Cancer Research Center
Start mint Lesion™ directly from your RIS / PACS while preserving the working context. Relevant image data is automatically synchronized with your PACS and results can be integrated into your RIS report.